Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Neomycin sulfate | 1405-10-3 | 99.86% | 5 G
SDP

Catalog No. 5000408391
Encompass_Preferred

Neomycin sulfate is an aminoglycoside antibiotic that exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. It is also a known phospholipase C (PLC) inhibitor. This compound can be used for cancer research and is involved in various clinical trials for conditions such as Crohn's Disease and colorectal neoplasms.

  • Inhibits nuclear translocation of angiogenin
  • Abolishes angiogenin-induced proliferation of HUVE cells
  • Inhibits IP3-mediated Ca2+ release
  • Depletes gut microbiota in specific mouse models
  • Can be used for cancer research

Catalog No. 50-004-08391 Supplier Medchemexpress LLC Supplier No. HYB04705G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Neomycin sulfate is an aminoglycoside antibiotic that exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. It is also a known phospholipase C (PLC) inhibitor. This compound can be used for cancer research and is involved in various clinical trials for conditions such as Crohn's Disease and colorectal neoplasms.

  • Inhibits nuclear translocation of angiogenin
  • Abolishes angiogenin-induced proliferation of HUVE cells
  • Inhibits IP3-mediated Ca2+ release
  • Depletes gut microbiota in specific mouse models
  • Can be used for cancer research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.